QRG Capital Management’s United Therapeutics UTHR Stock Holding History

QRG Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88M	Buy	3,476 +116	+3%	+$65.3K	0.02%	478
2026 Q1	$1.99M	Sell	3,360 -1,330	-28%	-$662K	0.02%	421
2025 Q4	$2.28M	Buy	4,690 +591	+14%	+$275K	0.03%	389
2025 Q3	$1.72M	Sell	4,099 -13,671	-77%	-$4.6M	0.02%	410
2025 Q2	$5.11M	Buy	17,770 +1,045	+6%	+$312K	0.04%	314
2025 Q1	$5.16M	Sell	16,725 -246	-1%	-$84.3K	0.05%	299
2024 Q4	$5.99M	Buy	16,971 +591	+4%	+$217K	0.06%	260
2024 Q3	$5.87M	Buy	16,380 +1,059	+7%	+$358K	0.06%	268
2024 Q2	$4.88M	Buy	15,321 +1,692	+12%	+$448K	0.06%	268
2024 Q1	$3.13M	Sell	13,629 -363	-3%	-$81.9K	0.04%	336
2023 Q4	$3.08M	Buy	13,992 +346	+3%	+$79.8K	0.05%	336
2023 Q3	$3.08M	Buy	+13,646	New	+$3.14M	0.05%	306

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

QRG Capital Management's UTHR Position: Q2 2026 in Review

QRG Capital Management increased its United Therapeutics (UTHR) stake by 3.5% in Q2 2026, buying an estimated $65.3K and bringing the position to 3,476 shares worth $1.88M. The position accounts for 0.02% of the portfolio, ranked #478.

QRG Capital Management first reported a position in UTHR in Q3 2023 and has held it in 12 quarters since. The position peaked at $5.99M in Q4 2024. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

QRG Capital Management held 3,476 shares of United Therapeutics worth $1.88M as of Q2 2026.
QRG Capital Management bought 116 United Therapeutics shares in Q2 2026, an estimated $65.3K.
United Therapeutics made up 0.02% of QRG Capital Management's portfolio in Q2 2026, its #478 holding.
QRG Capital Management first reported a position in United Therapeutics in Q3 2023 and has held it in 12 quarters since.
QRG Capital Management's United Therapeutics position peaked at $5.99M in Q4 2024.
884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.